MannKind Corporation · 12 hours ago
Packaging Technology Internship
MannKind Corporation focuses on the development and commercialization of innovative inhaled therapeutic products and devices. They are seeking a Packaging Technology Intern to learn about pharmaceutical packaging fundamentals and support project work within the Packaging Technology team.
BiotechnologyHealth CarePharmaceutical
Responsibilities
As a part of the Packaging Technology team, you will learn fundamentals of pharmaceutical packaging including package design, material testing, and labeling development
You will report to a Package Engineer and support their project work; this may involve working as a part of drug development team, problem solving a production line issue, or working with Supply Chain to set up new materials for use in Production
You will be required to operate independently and manage your time in order to complete a variety of tasks according to pre-defined due dates
This position is required to be on site 40 hours per week
Qualification
Required
Completing a major in a business-related discipline
3.0 GPA or equivalent preferred
Must be able to work 40 hours per week for the full 12 weeks (no vacation weeks) minus shut down the week of Fourth of July
You enjoy collaborating with others and can resolve conflict with tact and professionalism
You are fluent with Microsoft Office 365 and Teams
You have a general tech-savvy ability to leverage modern technology
This position is required to be on site 40 hours per week
Preferred
Preferably within 1-2 years of graduation
Prior experience within life sciences, pharmaceuticals, or biotech industries
Project management certification
Experience with project management software such as Asana, Microsoft Project/Planner
You possess superior time management and organizational skills
You have an intrinsic motivation to continually improve and optimize processes
You take the initiative to identify opportunities for improvement and act on them without needing constant direction
You are open to constructive criticism and use it to improve performance and grow professionally
Company
MannKind Corporation
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions.
Funding
Current Stage
Public CompanyTotal Funding
$475MKey Investors
Blackstone GroupDeerfield Capital Management
2025-08-06Post Ipo Debt· $75M
2021-03-02Post Ipo Debt· $200M
2018-12-01Post Ipo Equity· $40M
Recent News
2026-01-09
GlobeNewswire
2025-12-24
2025-12-24
Company data provided by crunchbase